These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33188385)

  • 21. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
    Marsot A
    J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
    Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
    Hernández ME; Ramos MJ; Ferrer NF
    Rev Panam Salud Publica; 2004 Nov; 16(5):315-9. PubMed ID: 15729980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
    van Maarseveen EM; Sprij A; Touw DJ
    Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.
    Kane Z; Gastine S; Obiero C; Williams P; Murunga S; Thitiri J; Ellis S; Correia E; Nyaoke B; Kipper K; van den Anker J; Sharland M; Berkley JA; Standing JF
    J Antimicrob Chemother; 2021 Jun; 76(7):1855-1864. PubMed ID: 33855449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
    Fuchs A; Li G; van den Anker JN; Bielicki J
    Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis.
    Gastine S; Obiero C; Kane Z; Williams P; Readman J; Murunga S; Thitiri J; Ellis S; Correia E; Nyaoke B; Kipper K; van den Anker J; Sharland M; Berkley JA; Standing JF
    J Antimicrob Chemother; 2022 Feb; 77(2):448-456. PubMed ID: 35107141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children.
    Shi HY; Wang K; Wang RH; Wu YE; Tang BH; Li X; Du B; Kan M; Zheng Y; Xu BP; Shen AD; Su LQ; Jacqz-Aigrain E; Huang X; Zhao W
    J Antimicrob Chemother; 2020 Jul; 75(7):1917-1924. PubMed ID: 32129861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.
    Bijleveld YA; van den Heuvel ME; Hodiamont CJ; Mathôt RA; de Haan TR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxicillin Dosing Regimens for the Treatment of Neonatal Sepsis: Balancing Efficacy and Neurotoxicity.
    van Donge T; Fuchs A; Leroux S; Pfister M; Rodieux F; Atkinson A; Giannoni E; van den Anker J; Bielicki J
    Neonatology; 2020; 117(5):619-627. PubMed ID: 32841941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
    Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
    Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
    Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
    Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
    Chen Y; Lu J; Dong M; Wu D; Zhu Y; Li Q; Chen C; Li Z
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.
    Traunmüller F; Popovic M; Konz KH; Vavken P; Leithner A; Joukhadar C
    Clin Pharmacokinet; 2011 Aug; 50(8):493-503. PubMed ID: 21740073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.